Dean Koh

The company currently boasts over 27 million monthly active users.

 Both companies will explore digital health business in developing countries and collaborate with international funders on new projects and business models.

The partnership will leverage on Holmusk’s GlycoLeap platform to help patients achieve weight loss and improved blood glucose control. 

Named Hospitech AwakeZone Medical, the JV will develop the production capabilities of Hospitech Respiration’s AnapnoGuard device in China and lead the commercialization of the device in the greater China market.

The Back on Track! program is available on the HeartVoice website and mobile app.

The Savonix Mobile app is available in Japan through the company’s partnerships with Fujitsu Connected Technologies Limited and Mitani Sangyo companies.Co, Ltd.  

Breathonix’s breath analysis technology works by detecting Volatile Organic Compounds (VOCs) present in a person’s exhaled breath.

This brings their total Pre-Series A round funding amount to $3.4 million.